Purpose
Kanamycin and Chloramphenicol resistant; destination vector engineered to integrate into the mycobacteriophage att-L5 site and designed to be used with the multisite Gateway cloning system
Available Since
Jan. 17, 2014
Availability
Academic Institutions and Nonprofits only